Recursive self improvement is the key to solving intelligence. Human intelligence is built on our ability to characterize the ...

AI is rewriting drug discovery. Recursion Pharmaceuticals and Tempus AI might be the platforms that turn early investors into ...

Recursive self improvement (RSI) is the key to solving intelligence. Human intelligence is built on our ability to ...

If you are wondering whether Recursion Pharmaceuticals is a bargain or a value trap at its current share price, this article ...

Had they included just one of Tony Hoare’s achievements, many scientific careers would be considered prestigious enough. His ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

The sweeping correction that most of these stocks have suffered was not only predictable, but it also reliably precedes a ...

In the last few years, Chinese AI startup MiniMax has become one of the most exciting in the crowded global AI marketplace, ...